Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Fortrea Holdings Inc. publishes a filing, an earnings call transcript or a press release.

Get FTRE alerts

About Mark Morais

Mark Morais is recorded as CFO and COO at Fortrea Holdings Inc. (FTRE). The newest filing on record that lists Mark Morais as COO at Fortrea Holdings Inc. (FTRE) is dated April 27, 2026. Fortrea Holdings Inc. reported in an 8-K filed July 3, 2023 that Mark Morais was appointed Chief Operating Officer and President, Clinical Services. The proxy statement of Fortrea Holdings Inc. reports total compensation of $1,616,788 for Mark Morais in fiscal 2025, including a base salary of $506,577. Disclosed compensation is on record for 4 fiscal years. Fortrea Holdings Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fortrea Holdings Inc. includes Anshul Thakral (CEO and Board Member), Peter M. Neupert (CEO and Board Member), Thomas Pike (CEO, Chairman and Board Member) and 7 others.

“Mark Morais, President of Clinical Development and Commercial Solutions, within Labcorp Drug Development, and Chief Operating Officer and President of Labcorp Clinical Development, will serve as our Chief Operating Officer and President, Clinical Services.”
Fortrea Holdings Inc. Form 8-K, filed July 3, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Fortrea Holdings Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Fortrea Holdings Inc. (FTRE) $506,577 $1,616,788
2024 Fortrea Holdings Inc. (FTRE) $503,846 $1,336,761
2023 Fortrea Holdings Inc. (FTRE) $456,900 $3,230,173
2022 Fortrea Holdings Inc. (FTRE) $413,800 $896,351

Recent activity